Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Mr. Arnold A. Pinkston

Corporate Vice President & General Counsel

Ms. Christine Z. McCauley

Corporate Vice President of Human Resources

Mr. Gary I. Sorsher

Senior Vice President of Quality & Regulatory Compliance

Mr. Dirksen J. Lehman

Corporate Vice President of Public Affairs

Dr. Todd J. Brinton FACC, M.D.

Corporate Vice President of Advanced Technology & Chief Scientific Officer

Mr. Scott B. Ullem

Corporate Vice President & Chief Financial Officer

Mr. Donald E. Bobo Jr.

Corporate Vice President of Strategy & Corporate Development

Mr. Larry L. Wood

Corporate Vice President and Group President of TAVR & Surgical Structural Heart

Mr. Bernard J. Zovighian

Chief Executive Officer & Director

Mark  Wilterding

Vice President of Investor Relations

Name	Marktkapitalisierung
SofWave Medical Ltd.	0M
Eiken Chemical Co., Ltd.	0M
QHSLab, Inc.	0M
Qlife Holding AB (publ)	0M
Vitrolife AB (publ)	0M
ReWalk Robotics Ltd.	0M
Bone Biologics Corporation	0M
Sinocare Inc.	0M
Hyperfine, Inc.	0M
Viemed Healthcare, Inc.	0M

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation Liste der Konkurrenten

Wichtigste Wettbewerber